Supplementary video 2 from Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy

<p>Video S2</p>

Furkejuvvon:

Bibliográfalaš dieđut
Váldodahkki:	Alvaro Teijeira (14962650) (author)
Eará dahkkit:	Saray Garasa (14962653) (author), Carlos Luri-Rey (14962656) (author), Carlos de Andrea (14962659) (author), Maria Gato (14962662) (author), Carmen Molina (14962665) (author), Tsuneyasu Kaisho (14962668) (author), Assunta Cirella (14962671) (author), Arantza Azpilikueta (14962674) (author), Steffanie K. Wculek (14962677) (author), Josune Egea (14962680) (author), Irene Olivera (14962683) (author), Inmaculada Rodriguez (14962686) (author), Ana Rouzaut (14962689) (author), Vladislav Verkhusha (14962692) (author), Karmele Valencia (14962695) (author), David Sancho (14962698) (author), Pedro Berraondo (14931434) (author), Ignacio Melero (14962701) (author)
Almmustuhtton:	2025
Fáttát:	Cancer Immuno-oncology Immunology Dendritic cells Immune responses to cancer Immunotherapy Agonist antibodies Checkpoint blockade
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid